The Northwestern Medicine Transplant and Immunocompromised Host Infectious Diseases Service strives to provide excellent clinical care for patients throughout the transplant process. We care for patients in the Comprehensive Transplant Center and the Robert H. Lurie Comprehensive Cancer Center.
This complex patient population includes: kidney, liver, pancreas/islet cell, heart, lung, autologous and allogeneic stem cell transplant candidates and recipients as well as patients with advanced heart or lung failure requiring ventricular assist devices or extracorporeal membrane oxygenation (ECMO).
We collaborate daily with the transplant surgeons, medical transplant teams, transplant pharmacists, and social workers to optimize outcomes for our patients. We offer continuity of care in both the hospital and clinic.
Our interactions include:
- Pre-transplant screening and vaccinations
- Treating infections that occur while awaiting a transplant
- Treating infections in the peri-operative period
- Continued surveillance, care, education and counseling after transplantation
In addition to our multidisciplinary care of these patients, we are also strongly committed to advancement of the field through education and research. Our division participates in leading clinical trials to provide our patients with increased access to transplantation and effective therapies, with the goal of improved health and quality of life while advancing the scientific knowledge in this arena.